- February 2022 – Sinclair Pharma announced the acquisition of Viora. This acquisition helped the company to expand its aesthetic products portfolio in the U.S. market.
- November 2021 – For the pre-establishment of the local anesthetic Lidocaine with their HA filler Perfecth, Sinclair Pharma declared the grant of a CE mark. This results in the expansion of the company’s portfolio in Europe-based countries.
- September 2021 – Galderma launched RESTYLANE EYELIGHT at Aesthetic & Anti-Aging Medicine World Congress (AMWC) and presented the data from its aesthetics portfolio.
- May 2021 – MaiLi, a new hyaluronic acid (HA) facial filler was introduced by Sinclair Pharma. The company said that MaiLi has four products in its product portfolio – Define, Volume, Extreme, and Precise.
- January 2021 – Merz Pharma and Candela Corporation announced a commercial collaboration to create a broad medical aesthetics portfolio.